TRIM21 was observed to have protective roles in IBD by downregulating some pro‐inflammatory cytokines (e.g., IL‐6 and TNF‐α) and inhibiting CD4+ T cell differentiation into Th1 and Th17 cells.58, 59. This evidence concerns the gene IL6 and inflammatory bowel disease.